Malassezia restricta-mediated Lipoperoxidation: A Novel Trigger in Dandruff.
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
15 Feb 2023
15 Feb 2023
Historique:
received:
27
09
2022
accepted:
19
01
2023
entrez:
15
2
2023
pubmed:
16
2
2023
medline:
17
2
2023
Statut:
epublish
Résumé
Dandruff is a common scalp disorder with multiple microbial and host-related factors contributing to its aetiology, including alterations in scalp sebum. Despite existing evidence that the yeast Malassezia restricta plays a key role in the onset of dandruff, the interplay of these factors is poorly understood. Recently, squalene monohydroperoxide and malondialdehyde were established as biomarkers of dandruff-afflicted scalp, highlighting the role of sebum lipoperoxidation in the triggering and maintenance of dandruff, although its mechanism of action is unknown. The current study provides evidence that M. restricta mediates sebum peroxidation, leading to production of squalene monohydroperoxide and malondialdehyde. Furthermore, in vitro data show that these lipoperoxidation products act on epidermal cells and alter the skin barrier. These results support the role of Malassezia restricta-induced lipoperoxides as triggers of dandruff, which suggests that blocking their production could be a novel anti-dandruff treatment approach.
Identifiants
pubmed: 36789756
doi: 10.2340/actadv.v103.4808
pmc: PMC9944333
doi:
Substances chimiques
2,3-oxidosqualene
0
Malondialdehyde
4Y8F71G49Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00868Références
J Lipid Res. 2007 Dec;48(12):2779-87
pubmed: 17848584
J Investig Dermatol Symp Proc. 2005 Dec;10(3):194-7
pubmed: 16382662
Antonie Van Leeuwenhoek. 1996 May;69(4):337-55
pubmed: 8836432
J Toxicol Sci. 1984 May;9(2):151-9
pubmed: 6481825
J Invest Dermatol. 1986 Jul;87(1):108-12
pubmed: 3088129
Antioxidants (Basel). 2020 Feb 26;9(3):
pubmed: 32111015
Sci Rep. 2018 Aug 14;8(1):12086
pubmed: 30108245
Arch Dermatol Res. 2016 Nov;308(9):631-642
pubmed: 27600510
Oxid Med Cell Longev. 2014;2014:360438
pubmed: 24999379
PLoS One. 2019 Dec 18;14(12):e0225796
pubmed: 31851674
Acta Derm Venereol. 2013 Mar 27;93(2):131-7
pubmed: 22875203
Methods Mol Biol. 2015;1312:465-8
pubmed: 26044028
J Invest Dermatol. 2013 Aug;133(8):2023-30
pubmed: 23448877
Br J Dermatol. 2014 Oct;171(4):760-70
pubmed: 24815089
J Lipid Res. 2008 Feb;49(2):271-81
pubmed: 17975220
J Clin Investig Dermatol. 2015 Dec;3(2):
pubmed: 27148560
Mediators Inflamm. 2010;2010:321494
pubmed: 20981292
J Invest Dermatol. 2003 Jun;120(6):915-22
pubmed: 12787115
Photochem Photobiol. 2015 Jul-Aug;91(4):966-70
pubmed: 25682789
Acta Dermatovenerol Croat. 2013;21(2):80-5
pubmed: 24001414
Photochem Photobiol. 1989 May;49(5):711-6
pubmed: 2756005
Int J Cosmet Sci. 2012 Aug;34(4):298-306
pubmed: 22515370
Toxicol In Vitro. 2018 Aug;50:418-425
pubmed: 29339149
Exp Dermatol. 2015 May;24(5):398-400
pubmed: 25739873
Int J Cosmet Sci. 2013 Apr;35(2):169-75
pubmed: 23106637
Biol Pharm Bull. 2009 Sep;32(9):1504-9
pubmed: 19721223
Cell Host Microbe. 2021 Aug 11;29(8):1235-1248.e8
pubmed: 34214492
Exp Dermatol. 1996 Feb;5(1):49-56
pubmed: 8624612
Exp Dermatol. 2012 Nov;21(11):871-5
pubmed: 23163654
J Invest Dermatol. 2006 Nov;126(11):2430-7
pubmed: 16778793
Front Endocrinol (Lausanne). 2021 Jan 21;11:607076
pubmed: 33551998
J Invest Dermatol. 2021 Jan;141(1):228-231.e4
pubmed: 32522484
PLoS One. 2013;8(3):e58203
pubmed: 23483996
Arch Dermatol Res. 2016 Apr;308(3):153-63
pubmed: 26842231
Int J Cosmet Sci. 2021 Apr;43(2):235-245
pubmed: 33469935
J Chromatogr A. 2000 Sep 8;891(2):267-73
pubmed: 11043787